Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
185.77
+3.62 (1.99%)
Dec 20, 2024, 4:00 PM EST - Market closed
CRL Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for CRL stock have an average target of 211.64, with a low estimate of 151 and a high estimate of 250. The average target predicts an increase of 13.93% from the current stock price of 185.77.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for CRL stock from 13 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
Buy | 4 | 2 | 2 | 0 | 0 | 0 |
Hold | 7 | 9 | 9 | 10 | 9 | 9 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 2 | 2 | 2 |
Total | 14 | 13 | 13 | 14 | 13 | 13 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
B of A Securities | B of A Securities | Hold Maintains $220 → $210 | Hold | Maintains | $220 → $210 | +13.04% | Dec 13, 2024 |
TD Cowen | TD Cowen | Hold Maintains $203 → $227 | Hold | Maintains | $203 → $227 | +22.19% | Nov 11, 2024 |
UBS | UBS | Strong Buy Maintains $240 → $250 | Strong Buy | Maintains | $240 → $250 | +34.58% | Nov 7, 2024 |
Evercore ISI Group | Evercore ISI Group | Hold Maintains $190 → $225 | Hold | Maintains | $190 → $225 | +21.12% | Nov 7, 2024 |
Redburn Atlantic | Redburn Atlantic | Strong Sell Initiates $151 | Strong Sell | Initiates | $151 | -18.72% | Oct 14, 2024 |
Financial Forecast
Revenue This Year
4.07B
from 4.13B
Decreased by -1.39%
Revenue Next Year
4.12B
from 4.07B
Increased by 1.18%
EPS This Year
10.30
from 9.22
Increased by 11.73%
EPS Next Year
10.35
from 10.30
Increased by 0.48%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 4.3B | 4.5B | 4.8B | |||
Avg | 4.1B | 4.1B | 4.4B | |||
Low | 3.9B | 3.9B | 4.1B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 3.0% | 9.7% | 16.0% | |||
Avg | -1.4% | 1.2% | 6.2% | |||
Low | -4.8% | -4.2% | -0.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 10.83 | 11.34 | 12.83 | ||
Avg | 10.30 | 10.35 | 11.58 | ||
Low | 9.85 | 8.84 | 10.68 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 17.4% | 10.1% | 24.0% | ||
Avg | 11.7% | 0.5% | 11.9% | ||
Low | 6.8% | -14.2% | 3.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.